Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

First clinical results on antibacterial OP-0595

April 27, 2015

In vitro test first to detect psychiatric adverse events of drugs

April 27, 2015

Lack of mitochondrial toxicity of AL-335 and AL-516

April 27, 2015

Novel PDE10 inhibitor demonstrates highly potent and selective tumor cell growth inhibitory activity

April 27, 2015

Karus Therapeutics presents PI3Kbeta/delta inhibitors

April 24, 2015

Clinical data reported for antibody-drug conjugate SGN-CD33A

April 24, 2015

Shanghai De Novo Pharmatech characterizes AML candidate SC-110237

April 24, 2015

First patient safety and pharmacokinetic data reported for LOXO-101

April 23, 2015

Tolerability, activity of antibody-drug conjugate SAR-408701 encourage clinical development

April 23, 2015

Mission Therapeutics describes novel UCH-L1 inhibitors tested in vivo

April 23, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...